Company / Net Income
CANNAPHARMARX, INC. Net Income History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$11.1M
FY2025
5-year range
-$19.9M / -$8.5M
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 10 years, ranging from -$20M in FY2019 to -$6,633 in FY2017.
Based on SEC 10-K filings.
-$11M in FY2025.
Declined from -$9M to -$11M over the past 3 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income decreased 12.4% year-over-year.
- Peak net income was recorded in FY2017.
- Lowest net income in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$11.1M | -12.4% |
| FY2024 | -$9.9M | -16.1% |
| FY2022 | -$8.5M | +3.4% |
| FY2021 | -$8.8M | +55.6% |
| FY2020 | -$19.9M | +2.7% |
| FY2019 | -$20.5M | -560.9% |
| FY2018 | -$3.1M | -46550.2% |
| FY2017 | -$6.6K | +99.3% |
| FY2016 | -$1.0M | +91.5% |
| FY2015 | -$11.7M | -195.2% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026